In vitro inflammation and toxicity assessment of pre- and post-incinerated organomodified nanoclays to macrophages using high-throughput screening approaches
Organomodified nanoclays (ONC), two-dimensional montmorillonite with organic coatings, are increasingly used to improve nanocomposite properties. However, little is known about pulmonary health risks along the nanoclay life cycle even with increased evidence of airborne particulate exposures in occu...
Saved in:
| Published in | Particle and fibre toxicology Vol. 21; no. 1; pp. 16 - 28 |
|---|---|
| Main Authors | , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
BioMed Central Ltd
21.03.2024
BioMed Central BMC |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Organomodified nanoclays (ONC), two-dimensional montmorillonite with organic coatings, are increasingly used to improve nanocomposite properties. However, little is known about pulmonary health risks along the nanoclay life cycle even with increased evidence of airborne particulate exposures in occupational environments. Recently, oropharyngeal aspiration exposure to pre- and post-incinerated ONC in mice caused low grade, persistent lung inflammation with a pro-fibrotic signaling response with unknown mode(s) of action. We hypothesized that the organic coating presence and incineration status of nanoclays determine the inflammatory cytokine secretary profile and cytotoxic response of macrophages. To test this hypothesis differentiated human macrophages (THP-1) were acutely exposed (0-20 µg/cm
) to pristine, uncoated nanoclay (CloisNa), an ONC (Clois30B), their incinerated byproducts (I-CloisNa and I-Clois30B), and crystalline silica (CS) followed by cytotoxicity and inflammatory endpoints. Macrophages were co-exposed to lipopolysaccharide (LPS) or LPS-free medium to assess the role of priming the NF-κB pathway in macrophage response to nanoclay treatment. Data were compared to inflammatory responses in male C57Bl/6J mice following 30 and 300 µg/mouse aspiration exposure to the same particles.
In LPS-free media, CloisNa exposure caused mitochondrial depolarization while Clois30B exposure caused reduced macrophage viability, greater cytotoxicity, and significant damage-associated molecular patterns (IL-1α and ATP) release compared to CloisNa and unexposed controls. LPS priming with low CloisNa doses caused elevated cathepsin B/Caspage-1/IL-1β release while higher doses resulted in apoptosis. Clois30B exposure caused dose-dependent THP-1 cell pyroptosis evidenced by Cathepsin B and IL-1β release and Gasdermin D cleavage. Incineration ablated the cytotoxic and inflammatory effects of Clois30B while I-CloisNa still retained some mild inflammatory potential. Comparative analyses suggested that in vitro macrophage cell viability, inflammasome endpoints, and pro-inflammatory cytokine profiles significantly correlated to mouse bronchioalveolar lavage inflammation metrics including inflammatory cell recruitment.
Presence of organic coating and incineration status influenced inflammatory and cytotoxic responses following exposure to human macrophages. Clois30B, with a quaternary ammonium tallow coating, induced a robust cell membrane damage and pyroptosis effect which was eliminated after incineration. Conversely, incinerated nanoclay exposure primarily caused elevated inflammatory cytokine release from THP-1 cells. Collectively, pre-incinerated nanoclay displayed interaction with macrophage membrane components (molecular initiating event), increased pro-inflammatory mediators, and increased inflammatory cell recruitment (two key events) in the lung fibrosis adverse outcome pathway. |
|---|---|
| AbstractList | Abstract Background Organomodified nanoclays (ONC), two-dimensional montmorillonite with organic coatings, are increasingly used to improve nanocomposite properties. However, little is known about pulmonary health risks along the nanoclay life cycle even with increased evidence of airborne particulate exposures in occupational environments. Recently, oropharyngeal aspiration exposure to pre- and post-incinerated ONC in mice caused low grade, persistent lung inflammation with a pro-fibrotic signaling response with unknown mode(s) of action. We hypothesized that the organic coating presence and incineration status of nanoclays determine the inflammatory cytokine secretary profile and cytotoxic response of macrophages. To test this hypothesis differentiated human macrophages (THP-1) were acutely exposed (0–20 µg/cm2) to pristine, uncoated nanoclay (CloisNa), an ONC (Clois30B), their incinerated byproducts (I-CloisNa and I-Clois30B), and crystalline silica (CS) followed by cytotoxicity and inflammatory endpoints. Macrophages were co-exposed to lipopolysaccharide (LPS) or LPS-free medium to assess the role of priming the NF-κB pathway in macrophage response to nanoclay treatment. Data were compared to inflammatory responses in male C57Bl/6J mice following 30 and 300 µg/mouse aspiration exposure to the same particles. Results In LPS-free media, CloisNa exposure caused mitochondrial depolarization while Clois30B exposure caused reduced macrophage viability, greater cytotoxicity, and significant damage-associated molecular patterns (IL-1α and ATP) release compared to CloisNa and unexposed controls. LPS priming with low CloisNa doses caused elevated cathepsin B/Caspage-1/IL-1β release while higher doses resulted in apoptosis. Clois30B exposure caused dose-dependent THP-1 cell pyroptosis evidenced by Cathepsin B and IL-1β release and Gasdermin D cleavage. Incineration ablated the cytotoxic and inflammatory effects of Clois30B while I-CloisNa still retained some mild inflammatory potential. Comparative analyses suggested that in vitro macrophage cell viability, inflammasome endpoints, and pro-inflammatory cytokine profiles significantly correlated to mouse bronchioalveolar lavage inflammation metrics including inflammatory cell recruitment. Conclusions Presence of organic coating and incineration status influenced inflammatory and cytotoxic responses following exposure to human macrophages. Clois30B, with a quaternary ammonium tallow coating, induced a robust cell membrane damage and pyroptosis effect which was eliminated after incineration. Conversely, incinerated nanoclay exposure primarily caused elevated inflammatory cytokine release from THP-1 cells. Collectively, pre-incinerated nanoclay displayed interaction with macrophage membrane components (molecular initiating event), increased pro-inflammatory mediators, and increased inflammatory cell recruitment (two key events) in the lung fibrosis adverse outcome pathway. Organomodified nanoclays (ONC), two-dimensional montmorillonite with organic coatings, are increasingly used to improve nanocomposite properties. However, little is known about pulmonary health risks along the nanoclay life cycle even with increased evidence of airborne particulate exposures in occupational environments. Recently, oropharyngeal aspiration exposure to pre- and post-incinerated ONC in mice caused low grade, persistent lung inflammation with a pro-fibrotic signaling response with unknown mode(s) of action. We hypothesized that the organic coating presence and incineration status of nanoclays determine the inflammatory cytokine secretary profile and cytotoxic response of macrophages. To test this hypothesis differentiated human macrophages (THP-1) were acutely exposed (0-20 µg/cm2) to pristine, uncoated nanoclay (CloisNa), an ONC (Clois30B), their incinerated byproducts (I-CloisNa and I-Clois30B), and crystalline silica (CS) followed by cytotoxicity and inflammatory endpoints. Macrophages were co-exposed to lipopolysaccharide (LPS) or LPS-free medium to assess the role of priming the NF-κB pathway in macrophage response to nanoclay treatment. Data were compared to inflammatory responses in male C57Bl/6J mice following 30 and 300 µg/mouse aspiration exposure to the same particles.BACKGROUNDOrganomodified nanoclays (ONC), two-dimensional montmorillonite with organic coatings, are increasingly used to improve nanocomposite properties. However, little is known about pulmonary health risks along the nanoclay life cycle even with increased evidence of airborne particulate exposures in occupational environments. Recently, oropharyngeal aspiration exposure to pre- and post-incinerated ONC in mice caused low grade, persistent lung inflammation with a pro-fibrotic signaling response with unknown mode(s) of action. We hypothesized that the organic coating presence and incineration status of nanoclays determine the inflammatory cytokine secretary profile and cytotoxic response of macrophages. To test this hypothesis differentiated human macrophages (THP-1) were acutely exposed (0-20 µg/cm2) to pristine, uncoated nanoclay (CloisNa), an ONC (Clois30B), their incinerated byproducts (I-CloisNa and I-Clois30B), and crystalline silica (CS) followed by cytotoxicity and inflammatory endpoints. Macrophages were co-exposed to lipopolysaccharide (LPS) or LPS-free medium to assess the role of priming the NF-κB pathway in macrophage response to nanoclay treatment. Data were compared to inflammatory responses in male C57Bl/6J mice following 30 and 300 µg/mouse aspiration exposure to the same particles.In LPS-free media, CloisNa exposure caused mitochondrial depolarization while Clois30B exposure caused reduced macrophage viability, greater cytotoxicity, and significant damage-associated molecular patterns (IL-1α and ATP) release compared to CloisNa and unexposed controls. LPS priming with low CloisNa doses caused elevated cathepsin B/Caspage-1/IL-1β release while higher doses resulted in apoptosis. Clois30B exposure caused dose-dependent THP-1 cell pyroptosis evidenced by Cathepsin B and IL-1β release and Gasdermin D cleavage. Incineration ablated the cytotoxic and inflammatory effects of Clois30B while I-CloisNa still retained some mild inflammatory potential. Comparative analyses suggested that in vitro macrophage cell viability, inflammasome endpoints, and pro-inflammatory cytokine profiles significantly correlated to mouse bronchioalveolar lavage inflammation metrics including inflammatory cell recruitment.RESULTSIn LPS-free media, CloisNa exposure caused mitochondrial depolarization while Clois30B exposure caused reduced macrophage viability, greater cytotoxicity, and significant damage-associated molecular patterns (IL-1α and ATP) release compared to CloisNa and unexposed controls. LPS priming with low CloisNa doses caused elevated cathepsin B/Caspage-1/IL-1β release while higher doses resulted in apoptosis. Clois30B exposure caused dose-dependent THP-1 cell pyroptosis evidenced by Cathepsin B and IL-1β release and Gasdermin D cleavage. Incineration ablated the cytotoxic and inflammatory effects of Clois30B while I-CloisNa still retained some mild inflammatory potential. Comparative analyses suggested that in vitro macrophage cell viability, inflammasome endpoints, and pro-inflammatory cytokine profiles significantly correlated to mouse bronchioalveolar lavage inflammation metrics including inflammatory cell recruitment.Presence of organic coating and incineration status influenced inflammatory and cytotoxic responses following exposure to human macrophages. Clois30B, with a quaternary ammonium tallow coating, induced a robust cell membrane damage and pyroptosis effect which was eliminated after incineration. Conversely, incinerated nanoclay exposure primarily caused elevated inflammatory cytokine release from THP-1 cells. Collectively, pre-incinerated nanoclay displayed interaction with macrophage membrane components (molecular initiating event), increased pro-inflammatory mediators, and increased inflammatory cell recruitment (two key events) in the lung fibrosis adverse outcome pathway.CONCLUSIONSPresence of organic coating and incineration status influenced inflammatory and cytotoxic responses following exposure to human macrophages. Clois30B, with a quaternary ammonium tallow coating, induced a robust cell membrane damage and pyroptosis effect which was eliminated after incineration. Conversely, incinerated nanoclay exposure primarily caused elevated inflammatory cytokine release from THP-1 cells. Collectively, pre-incinerated nanoclay displayed interaction with macrophage membrane components (molecular initiating event), increased pro-inflammatory mediators, and increased inflammatory cell recruitment (two key events) in the lung fibrosis adverse outcome pathway. Organomodified nanoclays (ONC), two-dimensional montmorillonite with organic coatings, are increasingly used to improve nanocomposite properties. However, little is known about pulmonary health risks along the nanoclay life cycle even with increased evidence of airborne particulate exposures in occupational environments. Recently, oropharyngeal aspiration exposure to pre- and post-incinerated ONC in mice caused low grade, persistent lung inflammation with a pro-fibrotic signaling response with unknown mode(s) of action. We hypothesized that the organic coating presence and incineration status of nanoclays determine the inflammatory cytokine secretary profile and cytotoxic response of macrophages. To test this hypothesis differentiated human macrophages (THP-1) were acutely exposed (0-20 µg/cm ) to pristine, uncoated nanoclay (CloisNa), an ONC (Clois30B), their incinerated byproducts (I-CloisNa and I-Clois30B), and crystalline silica (CS) followed by cytotoxicity and inflammatory endpoints. Macrophages were co-exposed to lipopolysaccharide (LPS) or LPS-free medium to assess the role of priming the NF-κB pathway in macrophage response to nanoclay treatment. Data were compared to inflammatory responses in male C57Bl/6J mice following 30 and 300 µg/mouse aspiration exposure to the same particles. In LPS-free media, CloisNa exposure caused mitochondrial depolarization while Clois30B exposure caused reduced macrophage viability, greater cytotoxicity, and significant damage-associated molecular patterns (IL-1α and ATP) release compared to CloisNa and unexposed controls. LPS priming with low CloisNa doses caused elevated cathepsin B/Caspage-1/IL-1β release while higher doses resulted in apoptosis. Clois30B exposure caused dose-dependent THP-1 cell pyroptosis evidenced by Cathepsin B and IL-1β release and Gasdermin D cleavage. Incineration ablated the cytotoxic and inflammatory effects of Clois30B while I-CloisNa still retained some mild inflammatory potential. Comparative analyses suggested that in vitro macrophage cell viability, inflammasome endpoints, and pro-inflammatory cytokine profiles significantly correlated to mouse bronchioalveolar lavage inflammation metrics including inflammatory cell recruitment. Presence of organic coating and incineration status influenced inflammatory and cytotoxic responses following exposure to human macrophages. Clois30B, with a quaternary ammonium tallow coating, induced a robust cell membrane damage and pyroptosis effect which was eliminated after incineration. Conversely, incinerated nanoclay exposure primarily caused elevated inflammatory cytokine release from THP-1 cells. Collectively, pre-incinerated nanoclay displayed interaction with macrophage membrane components (molecular initiating event), increased pro-inflammatory mediators, and increased inflammatory cell recruitment (two key events) in the lung fibrosis adverse outcome pathway. BackgroundOrganomodified nanoclays (ONC), two-dimensional montmorillonite with organic coatings, are increasingly used to improve nanocomposite properties. However, little is known about pulmonary health risks along the nanoclay life cycle even with increased evidence of airborne particulate exposures in occupational environments. Recently, oropharyngeal aspiration exposure to pre- and post-incinerated ONC in mice caused low grade, persistent lung inflammation with a pro-fibrotic signaling response with unknown mode(s) of action. We hypothesized that the organic coating presence and incineration status of nanoclays determine the inflammatory cytokine secretary profile and cytotoxic response of macrophages. To test this hypothesis differentiated human macrophages (THP-1) were acutely exposed (0–20 µg/cm2) to pristine, uncoated nanoclay (CloisNa), an ONC (Clois30B), their incinerated byproducts (I-CloisNa and I-Clois30B), and crystalline silica (CS) followed by cytotoxicity and inflammatory endpoints. Macrophages were co-exposed to lipopolysaccharide (LPS) or LPS-free medium to assess the role of priming the NF-κB pathway in macrophage response to nanoclay treatment. Data were compared to inflammatory responses in male C57Bl/6J mice following 30 and 300 µg/mouse aspiration exposure to the same particles.ResultsIn LPS-free media, CloisNa exposure caused mitochondrial depolarization while Clois30B exposure caused reduced macrophage viability, greater cytotoxicity, and significant damage-associated molecular patterns (IL-1α and ATP) release compared to CloisNa and unexposed controls. LPS priming with low CloisNa doses caused elevated cathepsin B/Caspage-1/IL-1β release while higher doses resulted in apoptosis. Clois30B exposure caused dose-dependent THP-1 cell pyroptosis evidenced by Cathepsin B and IL-1β release and Gasdermin D cleavage. Incineration ablated the cytotoxic and inflammatory effects of Clois30B while I-CloisNa still retained some mild inflammatory potential. Comparative analyses suggested that in vitro macrophage cell viability, inflammasome endpoints, and pro-inflammatory cytokine profiles significantly correlated to mouse bronchioalveolar lavage inflammation metrics including inflammatory cell recruitment.ConclusionsPresence of organic coating and incineration status influenced inflammatory and cytotoxic responses following exposure to human macrophages. Clois30B, with a quaternary ammonium tallow coating, induced a robust cell membrane damage and pyroptosis effect which was eliminated after incineration. Conversely, incinerated nanoclay exposure primarily caused elevated inflammatory cytokine release from THP-1 cells. Collectively, pre-incinerated nanoclay displayed interaction with macrophage membrane components (molecular initiating event), increased pro-inflammatory mediators, and increased inflammatory cell recruitment (two key events) in the lung fibrosis adverse outcome pathway. Organomodified nanoclays (ONC), two-dimensional montmorillonite with organic coatings, are increasingly used to improve nanocomposite properties. However, little is known about pulmonary health risks along the nanoclay life cycle even with increased evidence of airborne particulate exposures in occupational environments. Recently, oropharyngeal aspiration exposure to pre- and post-incinerated ONC in mice caused low grade, persistent lung inflammation with a pro-fibrotic signaling response with unknown mode(s) of action. We hypothesized that the organic coating presence and incineration status of nanoclays determine the inflammatory cytokine secretary profile and cytotoxic response of macrophages. To test this hypothesis differentiated human macrophages (THP-1) were acutely exposed (0-20 [micro]g/cm.sup.2) to pristine, uncoated nanoclay (CloisNa), an ONC (Clois30B), their incinerated byproducts (I-CloisNa and I-Clois30B), and crystalline silica (CS) followed by cytotoxicity and inflammatory endpoints. Macrophages were co-exposed to lipopolysaccharide (LPS) or LPS-free medium to assess the role of priming the NF-κB pathway in macrophage response to nanoclay treatment. Data were compared to inflammatory responses in male C57Bl/6J mice following 30 and 300 [micro]g/mouse aspiration exposure to the same particles. In LPS-free media, CloisNa exposure caused mitochondrial depolarization while Clois30B exposure caused reduced macrophage viability, greater cytotoxicity, and significant damage-associated molecular patterns (IL-1[alpha] and ATP) release compared to CloisNa and unexposed controls. LPS priming with low CloisNa doses caused elevated cathepsin B/Caspage-1/IL-1[beta] release while higher doses resulted in apoptosis. Clois30B exposure caused dose-dependent THP-1 cell pyroptosis evidenced by Cathepsin B and IL-1[beta] release and Gasdermin D cleavage. Incineration ablated the cytotoxic and inflammatory effects of Clois30B while I-CloisNa still retained some mild inflammatory potential. Comparative analyses suggested that in vitro macrophage cell viability, inflammasome endpoints, and pro-inflammatory cytokine profiles significantly correlated to mouse bronchioalveolar lavage inflammation metrics including inflammatory cell recruitment. Presence of organic coating and incineration status influenced inflammatory and cytotoxic responses following exposure to human macrophages. Clois30B, with a quaternary ammonium tallow coating, induced a robust cell membrane damage and pyroptosis effect which was eliminated after incineration. Conversely, incinerated nanoclay exposure primarily caused elevated inflammatory cytokine release from THP-1 cells. Collectively, pre-incinerated nanoclay displayed interaction with macrophage membrane components (molecular initiating event), increased pro-inflammatory mediators, and increased inflammatory cell recruitment (two key events) in the lung fibrosis adverse outcome pathway. Background Organomodified nanoclays (ONC), two-dimensional montmorillonite with organic coatings, are increasingly used to improve nanocomposite properties. However, little is known about pulmonary health risks along the nanoclay life cycle even with increased evidence of airborne particulate exposures in occupational environments. Recently, oropharyngeal aspiration exposure to pre- and post-incinerated ONC in mice caused low grade, persistent lung inflammation with a pro-fibrotic signaling response with unknown mode(s) of action. We hypothesized that the organic coating presence and incineration status of nanoclays determine the inflammatory cytokine secretary profile and cytotoxic response of macrophages. To test this hypothesis differentiated human macrophages (THP-1) were acutely exposed (0-20 [micro]g/cm.sup.2) to pristine, uncoated nanoclay (CloisNa), an ONC (Clois30B), their incinerated byproducts (I-CloisNa and I-Clois30B), and crystalline silica (CS) followed by cytotoxicity and inflammatory endpoints. Macrophages were co-exposed to lipopolysaccharide (LPS) or LPS-free medium to assess the role of priming the NF-κB pathway in macrophage response to nanoclay treatment. Data were compared to inflammatory responses in male C57Bl/6J mice following 30 and 300 [micro]g/mouse aspiration exposure to the same particles. Results In LPS-free media, CloisNa exposure caused mitochondrial depolarization while Clois30B exposure caused reduced macrophage viability, greater cytotoxicity, and significant damage-associated molecular patterns (IL-1[alpha] and ATP) release compared to CloisNa and unexposed controls. LPS priming with low CloisNa doses caused elevated cathepsin B/Caspage-1/IL-1[beta] release while higher doses resulted in apoptosis. Clois30B exposure caused dose-dependent THP-1 cell pyroptosis evidenced by Cathepsin B and IL-1[beta] release and Gasdermin D cleavage. Incineration ablated the cytotoxic and inflammatory effects of Clois30B while I-CloisNa still retained some mild inflammatory potential. Comparative analyses suggested that in vitro macrophage cell viability, inflammasome endpoints, and pro-inflammatory cytokine profiles significantly correlated to mouse bronchioalveolar lavage inflammation metrics including inflammatory cell recruitment. Conclusions Presence of organic coating and incineration status influenced inflammatory and cytotoxic responses following exposure to human macrophages. Clois30B, with a quaternary ammonium tallow coating, induced a robust cell membrane damage and pyroptosis effect which was eliminated after incineration. Conversely, incinerated nanoclay exposure primarily caused elevated inflammatory cytokine release from THP-1 cells. Collectively, pre-incinerated nanoclay displayed interaction with macrophage membrane components (molecular initiating event), increased pro-inflammatory mediators, and increased inflammatory cell recruitment (two key events) in the lung fibrosis adverse outcome pathway. Keywords: Nanoclay, Organic coating, Incineration, Silicates, In vitro models, High-throughput screening, Human lung cells, Mouse |
| ArticleNumber | 16 |
| Audience | Academic |
| Author | Wagner, Alixandra Friend, Sherri A. Derk, Raymond Coyle, Jayme P. Agarwal, Sushant Kornberg, Tiffany G. Dinu, Cerasela Zoica Gupta, Rakesh K. Dozier, Alan Rojanasakul, Liying W. Stueckle, Todd A. Jensen, Jake |
| Author_xml | – sequence: 1 givenname: Todd A. surname: Stueckle fullname: Stueckle, Todd A. – sequence: 2 givenname: Jake surname: Jensen fullname: Jensen, Jake – sequence: 3 givenname: Jayme P. surname: Coyle fullname: Coyle, Jayme P. – sequence: 4 givenname: Raymond surname: Derk fullname: Derk, Raymond – sequence: 5 givenname: Alixandra surname: Wagner fullname: Wagner, Alixandra – sequence: 6 givenname: Cerasela Zoica surname: Dinu fullname: Dinu, Cerasela Zoica – sequence: 7 givenname: Tiffany G. surname: Kornberg fullname: Kornberg, Tiffany G. – sequence: 8 givenname: Sherri A. surname: Friend fullname: Friend, Sherri A. – sequence: 9 givenname: Alan surname: Dozier fullname: Dozier, Alan – sequence: 10 givenname: Sushant surname: Agarwal fullname: Agarwal, Sushant – sequence: 11 givenname: Rakesh K. surname: Gupta fullname: Gupta, Rakesh K. – sequence: 12 givenname: Liying W. surname: Rojanasakul fullname: Rojanasakul, Liying W. |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38509617$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kstu3CAUhq0qVXNpX6CLylI37cIpGBhgVUVRLyNFqtTLGh1jbDOywQUcJQ_Tdy0zk6aZqKpYcDnf_9sc_tPiyHlniuIlRucYi9W7iGspZIVqWiHEOK_4k-IEc0oqITk_erA-Lk5j3CBEmGD4WXFMBENyhflJ8Wvtymubgi-t60aYJkjWuxJcWyZ_Y7VNtyXEaGKcjEul78o5mGpXn31MlXXaOhMgmbb0oQfnJ9_azuatyxs9wm3MTuUEOvh5gN7EconW9eVg-6FKQ_BLP8xLKqMOxrhtBeY5eNCDic-Lpx2M0by4m8-KHx8_fL_8XF19-bS-vLiqNJMiVdSwutENRXWndQ01B91RKYDTVhDT1bLBxFBoCRVIMENaLiWYZoWQRC00HTkr1nvf1sNGzcFOEG6VB6t2B_liCkKyejSKcSFZh7DWrKUrJiQiHSMUGtIa2eI6e73fe81LM5lW57YFGA9MDyvODqr31wojyVY1ZdnhzZ1D8D8XE5OabNRmHMEZv0RVS04wwgLRjL5-hG78ElzulSKIcMEZZewv1UO-QX5onz-st6bqgouVpAKzVabO_0Hl0ZrJ6hy9zubzA8HbA0FmkrlJPSwxqvW3r4fsq4dduW_HnyRmoN4DOScxBtPdIxipbdzVPu4qx13t4q62IvFIlAO7S3D-dTv-T_obAHkGtA |
| CitedBy_id | crossref_primary_10_3390_nano14181470 |
| Cites_doi | 10.4049/jimmunol.172.7.4618 10.1016/j.molimm.2018.09.010 10.1021/acs.chemrestox.6b00409 10.1007/978-1-4939-7357-6_2 10.1186/s12989-020-00371-1 10.3109/17435390.2015.1132346 10.1016/j.mrgentox.2021.503405 10.1016/j.actbio.2020.03.017 10.1016/j.tiv.2011.12.006 10.1007/BF02704606 10.1038/s41419-023-05786-0 10.7150/thno.34065 10.1038/s41577-019-0165-0 10.4049/jimmunol.1302470 10.1039/C8EN00420J 10.1186/s12989-016-0162-4 10.1186/s12989-023-00516-y 10.1016/j.envres.2014.12.024 10.1146/annurev-immunol-032712-095937 10.3390/ijms20133328 10.1007/s00204-019-02604-5 10.1053/ai.1994.v94.a52646 10.1016/j.progsurf.2014.08.002 10.1084/jem.181.5.1661 10.4103/ed.ed_16_18 10.1016/j.impact.2016.11.001 10.1180/claymin.2009.044.2.161 10.1016/S0300-483X(00)00415-7 10.1007/s00204-005-0013-9 10.1590/S1516-14392013005000114 10.2478/s13382-013-0137-8 10.1021/acs.chemrestox.9b00277 10.1016/j.mrgentox.2014.04.023 10.1016/j.taap.2017.01.012 10.1016/j.envpol.2023.122950 10.1021/nn102734s 10.1016/j.taap.2013.11.012 10.1186/1743-8977-11-17 10.3390/toxics10050232 10.1093/toxsci/kfu199 10.4049/jimmunol.0900459 10.1063/1.4937927 10.1152/ajplung.00329.2004 10.1016/j.impact.2017.12.002 10.1038/s41598-018-28884-y 10.1042/CBI20100587 10.1007/s11051-012-0989-z 10.1080/17435390.2020.1771786 10.1007/978-1-4939-7357-6_3 10.1080/17435390.2017.1287313 10.1021/acsami.7b06657 10.1186/1743-8977-7-39 10.1080/08958370252870998 10.1021/acsnano.7b07281 10.1186/1743-8977-10-26 10.1016/j.bbagen.2016.09.003 10.1021/ar300022h 10.1002/adv.21368 10.1016/j.mrgentox.2012.10.006 10.1016/j.mrgentox.2010.04.021 10.1016/j.envpol.2023.122997 10.1089/107999003321455453 10.1289/ehp.1306561 10.18637/jss.v012.i05 10.1016/j.fct.2013.03.043 10.1152/ajpcell.00298.2015 10.1038/ncomms4514 10.1007/s10453-010-9179-6 10.4209/aaqr.2008.01.0001 10.3389/fimmu.2018.01120 10.1615/CritRevTherDrugCarrierSyst.v21.i4.10 10.1038/nature18629 10.15252/embj.2019102065 10.1186/s12989-020-00345-3 10.1164/ajrccm/146.2.454 10.1186/s12989-014-0069-x 10.1515/msp-2015-0008 10.1007/s00011-007-6115-5 10.1007/s11051-017-3850-6 10.1016/j.jhazmat.2015.10.018 10.1073/pnas.1015476108 10.3389/fimmu.2016.00097 10.1016/j.diff.2022.10.001 10.1111/imr.12577 10.1002/jcp.29268 10.1016/j.ccc.2010.12.005 10.1002/(SICI)1097-4636(20000315)49:4<469::AID-JBM5>3.0.CO;2-A 10.1002/wnan.1794 10.1186/rr177 10.3109/17435390.2013.776123 10.1007/s10495-012-0798-y 10.1002/wnan.1413 10.1016/S0300-483X(02)00061-6 10.1186/1743-8977-10-5 10.1080/15287390590912612 10.1038/ni.2215 |
| ContentType | Journal Article |
| Copyright | 2024. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply. COPYRIGHT 2024 BioMed Central Ltd. 2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2024 |
| Copyright_xml | – notice: 2024. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply. – notice: COPYRIGHT 2024 BioMed Central Ltd. – notice: 2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2024 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM ISR 3V. 7SR 7U7 7X7 7XB 88E 8FD 8FE 8FG 8FI 8FJ 8FK ABJCF ABUWG AEUYN AFKRA ATCPS AZQEC BENPR BGLVJ BHPHI C1K CCPQU D1I DWQXO FR3 FYUFA GHDGH GNUQQ HCIFZ JG9 K9. KB. KR7 L6V M0S M1P M7S PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PTHSS PYCSY 7X8 5PM DOA |
| DOI | 10.1186/s12989-024-00577-7 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Science ProQuest Central (Corporate) Engineered Materials Abstracts Toxicology Abstracts Health & Medical Complete (ProQuest Database) ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland Agricultural & Environmental Science Collection ProQuest Central Essentials ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Materials Science Collection ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection Materials Research Database ProQuest Health & Medical Complete (Alumni) Materials Science Database Civil Engineering Abstracts ProQuest Engineering Collection ProQuest Health & Medical Collection Medical Database Engineering Database Environmental Science Database Materials Science Collection ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Engineering Collection Environmental Science Collection MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database Materials Research Database ProQuest Central Student ProQuest Central Essentials SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Engineered Materials Abstracts Health Research Premium Collection Natural Science Collection Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Engineering Database ProQuest One Academic Eastern Edition ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Environmental Science Collection ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database Engineering Research Database ProQuest One Academic ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central ProQuest Health & Medical Research Collection ProQuest Engineering Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Agricultural & Environmental Science Collection Materials Science Database ProQuest Materials Science Collection Civil Engineering Abstracts Toxicology Abstracts ProQuest SciTech Collection ProQuest Medical Library Materials Science & Engineering Collection ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Public Health |
| EISSN | 1743-8977 |
| EndPage | 28 |
| ExternalDocumentID | oai_doaj_org_article_57895f01cc5d4658903f534ab3de9d12 PMC10956245 A786948156 38509617 10_1186_s12989_024_00577_7 |
| Genre | Research Support, U.S. Gov't, Non-P.H.S Research Support, U.S. Gov't, P.H.S Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | United Kingdom United States |
| GeographicLocations_xml | – name: United Kingdom – name: United States |
| GrantInformation_xml | – fundername: NIEHS NIH HHS grantid: R01 ES022968 – fundername: National Science Foundation grantid: 1454230 – fundername: NIOSH Nanotechnology Research Center grantid: 939051L – fundername: NIOSH Nanotechnology Research Center grantid: 921043S – fundername: National Science Foundation grantid: 1434503 |
| GroupedDBID | --- 0R~ 123 29O 2WC 2XV 4P2 53G 5VS 7X7 7XC 88E 8FE 8FG 8FH 8FI 8FJ AAFWJ AAJSJ AASML AAYXX ABJCF ABUWG ACGFO ACGFS ACIWK ACPRK ADBBV ADRAZ ADUKV AENEX AEUYN AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS ATCPS BAPOH BCNDV BENPR BFQNJ BGLVJ BHPHI BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 D1I DIK DU5 E3Z EBD EBLON EBS EDH EMOBN F5P FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IHR INH INR ISR ITC KB. KQ8 L6V M1P M48 M7S M~E O5R O5S OK1 OVT PATMY PDBOC PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO PTHSS PYCSY RBZ RNS ROL RPM RSV SBL SOJ TR2 UKHRP WOQ WOW XSB CGR CUY CVF ECM EIF NPM PJZUB PPXIY PQGLB PMFND 3V. 7SR 7U7 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ JG9 K9. KR7 PKEHL PQEST PQUKI PRINS 7X8 5PM PUEGO |
| ID | FETCH-LOGICAL-c598t-4e52bcb402fcc2a27acf498a74d83ef29b13e4ad348085e3d799aeb60090dabf3 |
| IEDL.DBID | M48 |
| ISSN | 1743-8977 |
| IngestDate | Wed Aug 27 01:29:38 EDT 2025 Thu Aug 21 18:35:08 EDT 2025 Fri Jul 11 00:05:43 EDT 2025 Fri Jul 25 10:44:34 EDT 2025 Tue Jun 17 22:13:20 EDT 2025 Tue Jun 10 21:14:04 EDT 2025 Fri Jun 27 06:01:44 EDT 2025 Mon Jul 21 05:46:08 EDT 2025 Tue Jul 01 01:46:07 EDT 2025 Thu Apr 24 23:12:24 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | In vitro models Incineration Mouse Human lung cells High-throughput screening Silicates Nanoclay Organic coating |
| Language | English |
| License | 2024. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c598t-4e52bcb402fcc2a27acf498a74d83ef29b13e4ad348085e3d799aeb60090dabf3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12989-024-00577-7 |
| PMID | 38509617 |
| PQID | 3037875455 |
| PQPubID | 55352 |
| PageCount | 28 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_57895f01cc5d4658903f534ab3de9d12 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10956245 proquest_miscellaneous_2973101804 proquest_journals_3037875455 gale_infotracmisc_A786948156 gale_infotracacademiconefile_A786948156 gale_incontextgauss_ISR_A786948156 pubmed_primary_38509617 crossref_primary_10_1186_s12989_024_00577_7 crossref_citationtrail_10_1186_s12989_024_00577_7 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2024-03-21 |
| PublicationDateYYYYMMDD | 2024-03-21 |
| PublicationDate_xml | – month: 03 year: 2024 text: 2024-03-21 day: 21 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationTitle | Particle and fibre toxicology |
| PublicationTitleAlternate | Part Fibre Toxicol |
| PublicationYear | 2024 |
| Publisher | BioMed Central Ltd BioMed Central BMC |
| Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
| References | TA Stueckle (577_CR17) 2018; 12 ZN Mohd Yasin (577_CR33) 2022; 128 N Kelley (577_CR65) 2019; 20 TT Le (577_CR92) 2014; 193 A Wagner (577_CR19) 2017; 9 KM Pollard (577_CR27) 2016; 7 DW Porter (577_CR24) 2002; 175 GN Joshi (577_CR61) 2013; 18 D Napierska (577_CR101) 2010; 7 G Janer (577_CR22) 2014; 8 S George (577_CR50) 2011; 5 S Tsai (577_CR8) 2008; 8 R Swiercz (577_CR89) 2013; 26 G DeLoid (577_CR41) 2014; 5 DL Villeneuve (577_CR29) 2014; 142 S Maisanaba (577_CR15) 2015; 138 Y Huang (577_CR4) 2013; 751 A Mackevica (577_CR6) 2016; 10 J Pourchez (577_CR10) 2018; 5 L Caceres (577_CR64) 2024; 341 AC Lopes (577_CR12) 2014; 89 C Ritz (577_CR52) 2005; 12 MA Katsnelson (577_CR60) 2016; 311 X Yuan (577_CR63) 2020; 10 S Maisanaba (577_CR21) 2016; 304 R Landsiedel (577_CR104) 2017; 19 C Degobbi (577_CR36) 2011; 27 G Wick (577_CR86) 2013; 31 MC Floody (577_CR11) 2009; 44 LB Zhuo (577_CR67) 2024; 341 S Maisanaba (577_CR71) 2013; 57 SL Re (577_CR81) 2010; 184 Z Xie (577_CR62) 2023; 14 Y Chen (577_CR82) 2014; 275 C Pavan (577_CR14) 2017; 30 V Wilhelmi (577_CR70) 2012; 26 577_CR37 N Zamzami (577_CR68) 1991; 181 LJ Cross (577_CR77) 2011; 27 MP Keane (577_CR91) 2002; 3 577_CR38 A Hubbs (577_CR46) 2005; 68 AR Collins (577_CR103) 2017; 9 S Geh (577_CR56) 2006; 80 D Yang (577_CR78) 2017; 280 P McLean (577_CR31) 2023; 20 KV Swanson (577_CR58) 2019; 19 DW Porter (577_CR100) 2002; 14 S Deville (577_CR69) 2020; 94 577_CR1 577_CR2 AM Gram (577_CR74) 2019; 38 F Jessop (577_CR59) 2017; 318 F Lu (577_CR34) 2020; 235 Q Liu (577_CR66) 2018; 103 S Lordan (577_CR57) 2012; 36 T Otsuki (577_CR80) 2007; 4 577_CR87 M Munasir (577_CR99) 2015; 33 F Mor (577_CR95) 2004; 172 A Wagner (577_CR16) 2017; 1861 KM Chambers (577_CR48) 2018; 1683 JR Roberts (577_CR76) 2013; 10 DS Lang (577_CR94) 2001; 159 AU Daniels (577_CR54) 2000; 49 CS-J Tsai (577_CR7) 2012; 14 E Di Ianni (577_CR25) 2020; 14 M Fei (577_CR96) 2011; 108 A Wagner (577_CR20) 2018; 8 TA Stueckle (577_CR18) 2019; 32 AK Sharma (577_CR23) 2014; 770 HA Patel (577_CR3) 2006; 29 V Rabolli (577_CR75) 2014; 11 X Liu (577_CR51) 2016; 535 Y Shang (577_CR35) 2018; 3 Z Adamis (577_CR13) 2005 X Chang (577_CR30) 2022; 10 CS Shi (577_CR79) 2012; 13 E Di Ianni (577_CR26) 2021; 872 TA Stueckle (577_CR45) 2017; 6 577_CR105 T Skuland (577_CR83) 2020; 17 T Morishige (577_CR102) 2010; 31 SM Fitzgerald (577_CR93) 2003; 23 D Simberg (577_CR73) 2004; 21 D Breznan (577_CR84) 2017; 11 EK Park (577_CR44) 2007; 56 A Nel (577_CR53) 2013; 46 E Jämsen (577_CR55) 2020; 108 JPDR Coyle (577_CR40) 2020; 17 JM Cohen (577_CR39) 2018; 10 KC Stone (577_CR47) 1992; 146 T Xia (577_CR43) 2013; 121 SJ Froggett (577_CR9) 2014; 11 BS Mandavilli (577_CR49) 2018; 1683 C Brandenberger (577_CR88) 2013; 10 R Ullah (577_CR97) 2014; 4 L Bieseki (577_CR98) 2013; 16 J Dong (577_CR85) 2018; 9 Y Yue (577_CR42) 2015; 107 AK Sharma (577_CR72) 2010; 700 E Di Ianni (577_CR32) 2022; 14 JA Bernstein (577_CR90) 1994; 94 M Sayan (577_CR28) 2016; 13 SLYZY Zeng (577_CR5) 1998; 16 |
| References_xml | – volume: 172 start-page: 4618 issue: 7 year: 2004 ident: 577_CR95 publication-title: J Immunol (Baltimore, Md: 1950) doi: 10.4049/jimmunol.172.7.4618 – volume: 103 start-page: 115 year: 2018 ident: 577_CR66 publication-title: Mol Immunol doi: 10.1016/j.molimm.2018.09.010 – volume: 30 start-page: 469 issue: 1 year: 2017 ident: 577_CR14 publication-title: Chem Res Toxicol doi: 10.1021/acs.chemrestox.6b00409 – volume: 1683 start-page: 21 year: 2018 ident: 577_CR48 publication-title: Methods Mol Biol (Clifton, NJ) doi: 10.1007/978-1-4939-7357-6_2 – volume: 17 start-page: 1 year: 2020 ident: 577_CR40 publication-title: Part Fibre Toxicol doi: 10.1186/s12989-020-00371-1 – volume: 10 start-page: 641 issue: 6 year: 2016 ident: 577_CR6 publication-title: Nanotoxicology doi: 10.3109/17435390.2015.1132346 – volume: 872 start-page: 503405 year: 2021 ident: 577_CR26 publication-title: Mutat Res Genet Toxicol Environ Mutagen doi: 10.1016/j.mrgentox.2021.503405 – volume: 108 start-page: 347 year: 2020 ident: 577_CR55 publication-title: Acta Biomater doi: 10.1016/j.actbio.2020.03.017 – volume: 26 start-page: 323 issue: 2 year: 2012 ident: 577_CR70 publication-title: Toxicol In Vitro doi: 10.1016/j.tiv.2011.12.006 – volume-title: Bentonite, kaolin and selected clay minerals year: 2005 ident: 577_CR13 – volume: 29 start-page: 133 issue: 2 year: 2006 ident: 577_CR3 publication-title: Bull Mater Sci doi: 10.1007/BF02704606 – volume: 14 start-page: 255 issue: 4 year: 2023 ident: 577_CR62 publication-title: Cell Death Disease doi: 10.1038/s41419-023-05786-0 – volume: 10 start-page: 4589 issue: 10 year: 2020 ident: 577_CR63 publication-title: Theranostics doi: 10.7150/thno.34065 – volume: 19 start-page: 477 issue: 8 year: 2019 ident: 577_CR58 publication-title: Nat Rev Immunol doi: 10.1038/s41577-019-0165-0 – volume: 193 start-page: 3755 issue: 7 year: 2014 ident: 577_CR92 publication-title: J Immunol (Baltimore, Md: 1950) doi: 10.4049/jimmunol.1302470 – volume: 5 start-page: 1951 issue: 8 year: 2018 ident: 577_CR10 publication-title: Environ Sci Nano doi: 10.1039/C8EN00420J – volume: 13 start-page: 51 issue: 1 year: 2016 ident: 577_CR28 publication-title: Part Fibre Toxicol doi: 10.1186/s12989-016-0162-4 – volume: 20 start-page: 5 issue: 1 year: 2023 ident: 577_CR31 publication-title: Part Fibre Toxicol doi: 10.1186/s12989-023-00516-y – volume: 138 start-page: 233 year: 2015 ident: 577_CR15 publication-title: Environ Res doi: 10.1016/j.envres.2014.12.024 – volume: 31 start-page: 107 year: 2013 ident: 577_CR86 publication-title: Annu Rev Immunol doi: 10.1146/annurev-immunol-032712-095937 – volume: 20 start-page: 3328 issue: 13 year: 2019 ident: 577_CR65 publication-title: Int J Mol Sci doi: 10.3390/ijms20133328 – volume: 94 start-page: 173 issue: 1 year: 2020 ident: 577_CR69 publication-title: Arch Toxicol doi: 10.1007/s00204-019-02604-5 – volume: 94 start-page: 257 issue: 2 Pt 1 year: 1994 ident: 577_CR90 publication-title: J Allergy Clin Immunol doi: 10.1053/ai.1994.v94.a52646 – volume: 89 start-page: 239 issue: 3 year: 2014 ident: 577_CR12 publication-title: Prog Surf Sci doi: 10.1016/j.progsurf.2014.08.002 – volume: 181 start-page: 1661 issue: 5 year: 1991 ident: 577_CR68 publication-title: J Exp Med doi: 10.1084/jem.181.5.1661 – volume: 3 start-page: 57 issue: 3 year: 2018 ident: 577_CR35 publication-title: Environ Dis doi: 10.4103/ed.ed_16_18 – volume: 6 start-page: 39 year: 2017 ident: 577_CR45 publication-title: NanoImpact doi: 10.1016/j.impact.2016.11.001 – volume: 44 start-page: 161 issue: 2 year: 2009 ident: 577_CR11 publication-title: Clay Miner doi: 10.1180/claymin.2009.044.2.161 – volume: 159 start-page: 81 issue: 1–2 year: 2001 ident: 577_CR94 publication-title: Toxicology doi: 10.1016/S0300-483X(00)00415-7 – volume: 80 start-page: 98 issue: 2 year: 2006 ident: 577_CR56 publication-title: Arch Toxicol doi: 10.1007/s00204-005-0013-9 – volume: 16 start-page: 1122 issue: 5 year: 2013 ident: 577_CR98 publication-title: Mater Res doi: 10.1590/S1516-14392013005000114 – volume: 26 start-page: 647 issue: 4 year: 2013 ident: 577_CR89 publication-title: Int J Occup Med Environ Health doi: 10.2478/s13382-013-0137-8 – volume: 32 start-page: 2445 issue: 12 year: 2019 ident: 577_CR18 publication-title: Chem Res Toxicol doi: 10.1021/acs.chemrestox.9b00277 – volume: 770 start-page: 66 year: 2014 ident: 577_CR23 publication-title: Mutat Res Genet Toxicol Environ Mutagen doi: 10.1016/j.mrgentox.2014.04.023 – volume: 318 start-page: 58 year: 2017 ident: 577_CR59 publication-title: Toxicol Appl Pharmacol doi: 10.1016/j.taap.2017.01.012 – volume: 341 start-page: 122950 year: 2024 ident: 577_CR67 publication-title: Environ Pollut (Barking, Essex: 1987) doi: 10.1016/j.envpol.2023.122950 – ident: 577_CR38 – volume: 5 start-page: 1805 issue: 3 year: 2011 ident: 577_CR50 publication-title: ACS Nano doi: 10.1021/nn102734s – volume: 275 start-page: 62 issue: 1 year: 2014 ident: 577_CR82 publication-title: Toxicol Appl Pharmacol doi: 10.1016/j.taap.2013.11.012 – volume: 11 start-page: 17 year: 2014 ident: 577_CR9 publication-title: Part Fibre Toxicol doi: 10.1186/1743-8977-11-17 – volume: 10 start-page: 232 issue: 5 year: 2022 ident: 577_CR30 publication-title: Toxics doi: 10.3390/toxics10050232 – volume: 142 start-page: 312 issue: 2 year: 2014 ident: 577_CR29 publication-title: Toxicol Sci doi: 10.1093/toxsci/kfu199 – volume: 184 start-page: 6367 issue: 11 year: 2010 ident: 577_CR81 publication-title: J Immunol doi: 10.4049/jimmunol.0900459 – volume: 107 start-page: 253103 issue: 25 year: 2015 ident: 577_CR42 publication-title: Appl Phys Lett doi: 10.1063/1.4937927 – ident: 577_CR87 doi: 10.1152/ajplung.00329.2004 – volume: 10 start-page: 81 year: 2018 ident: 577_CR39 publication-title: NanoImpact doi: 10.1016/j.impact.2017.12.002 – volume: 8 start-page: 10709 issue: 1 year: 2018 ident: 577_CR20 publication-title: Sci Rep doi: 10.1038/s41598-018-28884-y – volume: 36 start-page: 57 issue: 1 year: 2012 ident: 577_CR57 publication-title: Cell Biol Int doi: 10.1042/CBI20100587 – volume: 14 start-page: 989 issue: 7 year: 2012 ident: 577_CR7 publication-title: J Nanopart Res doi: 10.1007/s11051-012-0989-z – volume: 14 start-page: 869 issue: 7 year: 2020 ident: 577_CR25 publication-title: Nanotoxicology doi: 10.1080/17435390.2020.1771786 – volume: 1683 start-page: 33 year: 2018 ident: 577_CR49 publication-title: Methods in molecular biology (Clifton, NJ) doi: 10.1007/978-1-4939-7357-6_3 – volume: 16 start-page: 177 year: 1998 ident: 577_CR5 publication-title: Chin J Ind Hyg Occup Dis – volume: 11 start-page: 223 issue: 2 year: 2017 ident: 577_CR84 publication-title: Nanotoxicology doi: 10.1080/17435390.2017.1287313 – volume: 9 start-page: 32323 issue: 37 year: 2017 ident: 577_CR19 publication-title: ACS Appl Mater Interfaces doi: 10.1021/acsami.7b06657 – volume: 7 start-page: 39 issue: 1 year: 2010 ident: 577_CR101 publication-title: Part Fibre Toxicol doi: 10.1186/1743-8977-7-39 – volume: 4 start-page: 135 issue: 2 year: 2014 ident: 577_CR97 publication-title: Int J Compos Mater – volume: 14 start-page: 349 issue: 4 year: 2002 ident: 577_CR100 publication-title: Inhalation Toxicol doi: 10.1080/08958370252870998 – volume: 12 start-page: 2292 issue: 3 year: 2018 ident: 577_CR17 publication-title: ACS Nano doi: 10.1021/acsnano.7b07281 – ident: 577_CR37 – volume: 10 start-page: 26 year: 2013 ident: 577_CR88 publication-title: Part Fibre Toxicol doi: 10.1186/1743-8977-10-26 – volume: 1861 start-page: 3406 issue: 1 Pt A year: 2017 ident: 577_CR16 publication-title: Biochim Biophys Acta Gen Subj doi: 10.1016/j.bbagen.2016.09.003 – volume: 46 start-page: 607 issue: 3 year: 2013 ident: 577_CR53 publication-title: Acc Chem Res doi: 10.1021/ar300022h – ident: 577_CR2 doi: 10.1002/adv.21368 – volume: 751 start-page: 40 issue: 1 year: 2013 ident: 577_CR4 publication-title: Mutat Res Genet Toxicol Environ Mutagen doi: 10.1016/j.mrgentox.2012.10.006 – volume: 700 start-page: 18 issue: 1–2 year: 2010 ident: 577_CR72 publication-title: Mutat Res doi: 10.1016/j.mrgentox.2010.04.021 – volume: 341 start-page: 122997 year: 2024 ident: 577_CR64 publication-title: Environ Pollut (Barking, Essex: 1987) doi: 10.1016/j.envpol.2023.122997 – volume: 23 start-page: 57 issue: 2 year: 2003 ident: 577_CR93 publication-title: J Interferon Cytokine Res doi: 10.1089/107999003321455453 – volume: 121 start-page: 683 issue: 6 year: 2013 ident: 577_CR43 publication-title: Environ Health Perspect doi: 10.1289/ehp.1306561 – volume: 12 start-page: 1 issue: 5 year: 2005 ident: 577_CR52 publication-title: J Stat Softw doi: 10.18637/jss.v012.i05 – volume: 57 start-page: 266 year: 2013 ident: 577_CR71 publication-title: Food Chem Toxicol doi: 10.1016/j.fct.2013.03.043 – volume: 311 start-page: C83 issue: 1 year: 2016 ident: 577_CR60 publication-title: Am J Physiol Cell Physiol doi: 10.1152/ajpcell.00298.2015 – ident: 577_CR1 – volume: 5 start-page: 3514 year: 2014 ident: 577_CR41 publication-title: Nat Commun doi: 10.1038/ncomms4514 – volume: 27 start-page: 97 year: 2011 ident: 577_CR36 publication-title: Aerobiologia doi: 10.1007/s10453-010-9179-6 – volume: 8 start-page: 160 issue: 2 year: 2008 ident: 577_CR8 publication-title: Aerosol Air Qual Res doi: 10.4209/aaqr.2008.01.0001 – volume: 9 start-page: 1120 year: 2018 ident: 577_CR85 publication-title: Front Immunol doi: 10.3389/fimmu.2018.01120 – volume: 21 start-page: 257 issue: 4 year: 2004 ident: 577_CR73 publication-title: Crit Rev Ther Drug Carrier Syst doi: 10.1615/CritRevTherDrugCarrierSyst.v21.i4.10 – volume: 535 start-page: 153 issue: 7610 year: 2016 ident: 577_CR51 publication-title: Nature doi: 10.1038/nature18629 – ident: 577_CR105 – volume: 38 start-page: e102065 issue: 10 year: 2019 ident: 577_CR74 publication-title: EMBO J doi: 10.15252/embj.2019102065 – volume: 17 start-page: 13 issue: 1 year: 2020 ident: 577_CR83 publication-title: Part Fibre Toxicol doi: 10.1186/s12989-020-00345-3 – volume: 146 start-page: 454 issue: 2 year: 1992 ident: 577_CR47 publication-title: Am Rev Respir Dis doi: 10.1164/ajrccm/146.2.454 – volume: 11 start-page: 69 year: 2014 ident: 577_CR75 publication-title: Part Fibre Toxicol doi: 10.1186/s12989-014-0069-x – volume: 33 start-page: 47 issue: 1 year: 2015 ident: 577_CR99 publication-title: Mater Sci Pol doi: 10.1515/msp-2015-0008 – volume: 56 start-page: 45 issue: 1 year: 2007 ident: 577_CR44 publication-title: Inflamm Res doi: 10.1007/s00011-007-6115-5 – volume: 19 start-page: 171 issue: 5 year: 2017 ident: 577_CR104 publication-title: J Nanopart Res doi: 10.1007/s11051-017-3850-6 – volume: 304 start-page: 425 year: 2016 ident: 577_CR21 publication-title: J Hazard Mater doi: 10.1016/j.jhazmat.2015.10.018 – volume: 108 start-page: 5360 issue: 13 year: 2011 ident: 577_CR96 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1015476108 – volume: 7 start-page: 97 year: 2016 ident: 577_CR27 publication-title: Front Immunol doi: 10.3389/fimmu.2016.00097 – volume: 128 start-page: 67 year: 2022 ident: 577_CR33 publication-title: Differentiation doi: 10.1016/j.diff.2022.10.001 – volume: 280 start-page: 41 issue: 1 year: 2017 ident: 577_CR78 publication-title: Immunol Rev doi: 10.1111/imr.12577 – volume: 235 start-page: 3207 issue: 4 year: 2020 ident: 577_CR34 publication-title: J Cell Physiol doi: 10.1002/jcp.29268 – volume: 27 start-page: 355 issue: 2 year: 2011 ident: 577_CR77 publication-title: Crit Care Clin doi: 10.1016/j.ccc.2010.12.005 – volume: 49 start-page: 469 issue: 4 year: 2000 ident: 577_CR54 publication-title: J Biomed Mater Res doi: 10.1002/(SICI)1097-4636(20000315)49:4<469::AID-JBM5>3.0.CO;2-A – volume: 14 start-page: e1794 issue: 6 year: 2022 ident: 577_CR32 publication-title: Wiley Interdisc Rev Nanomed Nanobiotechnol doi: 10.1002/wnan.1794 – volume: 31 start-page: 6833 issue: 26 year: 2010 ident: 577_CR102 publication-title: ROS Prod Endosomal Rupture Biomater – volume: 4 start-page: 261 issue: 4 year: 2007 ident: 577_CR80 publication-title: Cell Mol Immunol – volume: 3 start-page: 5 issue: 1 year: 2002 ident: 577_CR91 publication-title: Respir Res doi: 10.1186/rr177 – volume: 8 start-page: 279 issue: 3 year: 2014 ident: 577_CR22 publication-title: Nanotoxicology doi: 10.3109/17435390.2013.776123 – volume: 18 start-page: 271 issue: 3 year: 2013 ident: 577_CR61 publication-title: Apoptosis doi: 10.1007/s10495-012-0798-y – volume: 9 start-page: e1413 issue: 1 year: 2017 ident: 577_CR103 publication-title: Wiley Interdiscip Rev Nanomed Nanobiotechnol doi: 10.1002/wnan.1413 – volume: 175 start-page: 63 issue: 1–3 year: 2002 ident: 577_CR24 publication-title: Toxicology doi: 10.1016/S0300-483X(02)00061-6 – volume: 10 start-page: 5 issue: 1 year: 2013 ident: 577_CR76 publication-title: Part Fibre Toxicol doi: 10.1186/1743-8977-10-5 – volume: 68 start-page: 999 issue: 11–12 year: 2005 ident: 577_CR46 publication-title: J Toxicol Environ Health A doi: 10.1080/15287390590912612 – volume: 13 start-page: 255 issue: 3 year: 2012 ident: 577_CR79 publication-title: Nat Immunol doi: 10.1038/ni.2215 |
| SSID | ssj0035851 |
| Score | 2.3848069 |
| Snippet | Organomodified nanoclays (ONC), two-dimensional montmorillonite with organic coatings, are increasingly used to improve nanocomposite properties. However,... Background Organomodified nanoclays (ONC), two-dimensional montmorillonite with organic coatings, are increasingly used to improve nanocomposite properties.... BackgroundOrganomodified nanoclays (ONC), two-dimensional montmorillonite with organic coatings, are increasingly used to improve nanocomposite properties.... Abstract Background Organomodified nanoclays (ONC), two-dimensional montmorillonite with organic coatings, are increasingly used to improve nanocomposite... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 16 |
| SubjectTerms | Ablation Air pollution Airborne particulates Ammonium Animals Apoptosis Cathepsin B Cathepsin B - metabolism Cathepsin B - pharmacology Cathepsins Cell membranes Cell viability Clay Coatings Combustion Comparative analysis Composite materials Cytokines Cytokines - metabolism Cytotoxicity Damage patterns Depolarization Development and progression Environmental aspects Exposure Fibrosis Fourier transforms Health aspects Health risks High-throughput screening High-Throughput Screening Assays Humans IL-1β Immune system In vitro models Incineration Inflammasomes Inflammation Inflammation - chemically induced Inflammation - metabolism Interleukin-1beta - metabolism Lavage Life cycles Lipopolysaccharides Lipopolysaccharides - pharmacology Lung diseases Lungs Macrophages Male Mice Montmorillonite Morphology Nanoclay Nanocomposites Nanoparticles NF-κB protein Occupational exposure Organic coating Organic coatings Priming Pyroptosis Risk factors Silica Silicates Surface chemistry Toxicity |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Na9VAEF-kJ0HEb6NVVhE8SDDZ3SS7xyqWVtCDWuht2c_2QZs8mjxp_xj_V2c2yeMFQS8eX3YSXmZm52Mz8xtC3tSscCwql5sImY6wyQ56mUvjuIPwuZIGzyG_fK2PTsTn0-p0Z9QX1oSN8MAj4yBhl6qKRelc5QW4S1XwWHFhLPdB-TRfmIHPm5Op0QZz_Ng1t8jI-n1fslQaxESO3ZdN3izcUELr_9Mm7zilZcHkjgc6vEfuTqEjPRj_8n1yK7QPyJ3x3I2O7UQPya_jlv5cDVcdBdUBaY-didS0ng7d9cpB0E3NFo2TdpFiHUhaX3f9kOPROwJRQyBK08Sn7rLzqwiBKm3hh7swNz08iV4anP11Dtaop1g7f0YR-Difxv6sNwMFewQ5Mq7MuOWhf0RODj_9-HiUTyMYclcpOeQiVMw6C0lmdI4Z1hgXhZKmEV7yEJmyJQ_CeC4kxG6B-0YpEyxEUarwxkb-mOy1XRueEupiWfgoBTcyiMZXFpIfaW1Re-atZGVGylki2k345Dgm40KnPEXWepSiBinqJEXdZOTd9p71iM7xV-oPKOgtJSJrpwvATj3pm_6XvmXkNaqJRuyMFotzzsym7_Xx92_6oJF1Ar-pM_J2IoodvIMzU68DcALhthaU-wtK2NxuuTxro56MS68h6gAzC6FvlZFX22W8Ewvm2tBtep1GkiE4m8jIk1F5t-_NJWL-lMAPuVDrBWOWK-3qPEGPl4hbyUT17H-w8jm5zdKW5Dkr98necLUJLyDEG-zLtJt_A6hvUEQ priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Technology Collection dbid: 8FG link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagXJAQ4k2gIIOQOKCoie0kzgkVxNIiwQGo1JvlZ7tSmyxNFsGP4b8y4zxohNTjxpNo4xl_Hk9mviHkVckyy0JtUx3gpCNMxEEnU6ktt-A-F1JjHPLzl_LgSHw6Lo7HgFs3plVOmBiB2rUWY-R7ALVgW7DfF283P1LsGoVfV8cWGtfJjRx2GkzpkquPExJz_OQ1FcrIcq_LWUwQYiLFGswqrRabUeTs_x-ZL21Ny7TJS_vQ6g65PTqQdH_Q-F1yzTf3yK0h-kaHoqL75M9hQ3-u-4uWggGBzof6RKobR_v219qC6031zMlJ20AxGySOb9quTzEAj3TU4I7S2PepPW_dOoC7Shv4Yc_07w6eRM81dgA7BUzqKGbQn1CkP07H5j-bbU8BleCkjCMTe7nvHpCj1Yfv7w_SsRFDaota9qnwBTPWwFEzWMs0q7QNopa6Ek5yH1htcu6FdlxI8OA8d1Vda2_Al6ozp03gD8lO0zb-MaE25JkLUnAtvahcYeAIJI3JSseckSxPSD5pRNmRpRybZZypeFqRpRq0qECLKmpRVQl5M9-zGTg6rpR-h4qeJZFfO16A6VTjclWAY3URstzawglw0uqMh4ILbbjztctZQl6imShk0GgwRedEb7tOHX77qvYrWUYKnDIhr0eh0MI7WD1WPMBMIOnWQnJ3IQlL3C6HJ2tUI8R06t-CSMiLeRjvxLS5xrfbTsXGZEjRJhLyaDDe-b25ROafHOZDLsx6MTHLkWZ9GgnIc2SvZKJ4cvX_ekpusrjYeMryXbLTX2z9M3DhevM8rtO_4K5IYg priority: 102 providerName: ProQuest |
| Title | In vitro inflammation and toxicity assessment of pre- and post-incinerated organomodified nanoclays to macrophages using high-throughput screening approaches |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/38509617 https://www.proquest.com/docview/3037875455 https://www.proquest.com/docview/2973101804 https://pubmed.ncbi.nlm.nih.gov/PMC10956245 https://doaj.org/article/57895f01cc5d4658903f534ab3de9d12 |
| Volume | 21 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBZ5XAql9F236aKWQg_FrS3JtnwoJSnZJoWEknZhb0LWI1nY2Nu1tyQ_pv-1I_lBTENPvSx4JRk0mhl9I4--QehNSiJFbK5CaSHSYYX3g5qHXCqqAD4nXLpzyJPT9GjGvs6T-Rbqyx11AqxvDe1cPanZevn-6uf1JzD4j97gefqhjolP_CEsdHcrszDbRruwM2WuosEJG74qUPcJrL84c-u40ebkOfz_9tQ3tqpxGuWNfWl6H93rACXebzXgAdoy5UN0tz2Nw-0lo0fo93GJfy2adYVhiqAD7X1FLEuNm-pqoQCKYzlwdOLKYpcd4ttXVd2E7kDe0VMDPMW-DlR1WemFBfiKS3hQS3ldw5vwpXQVwS7AR9XYZdSfY0eHHHbFgFabBoOXgsjZtfRs5qZ-jGbTwx-fj8KuMEOokpw3ITMJKVQBoadVikiSSWVZzmXGNKfGkryIqWFSU8YB0RmqszyXpgBslUdaFpY-QTtlVZpnCCsbR9pyRiU3LNNJASERL4oo1UQXnMQBivsVEapjLXfFM5bCRy88Fe0qClhF4VdRZAF6N4xZtZwd_-x94BZ66On4tv0fIE7Rma8Av5YnNoqVSjQD0JZH1CaUyYJqk-uYBOi1UxPhGDVKl7JzLjd1LY6_n4n9jKeeEicN0Nuuk61gDkp2NyBAEo6Ea9Rzb9QTTF6Nm3ttFL3FCMAi4HwBECcBejU0u5Euja401aYWvlCZo2xjAXraKu8wb8odE1AM8uAjtR4JZtxSLi48IXns2CwJS57_D1G-QHeIN0kakngP7TTrjXkJwK8pJmg7m2fwy6dfJmj34PD029nEH6JMvJ3_AbFdXKc |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKOYCEEG8WChgE4oCibmwncQ4IlUfp0scBWqk31_GjXalNliYL9MfwF_iNzDjJ0giptx43dqKNZ_zNjDPzDSEvUzY2zOcm0h4iHVEEHLQyktpwA-5zIjWeQ27vpBt74st-sr9E_vS1MJhW2WNiAGpbGTwjXwWoBd0Ce5-8m32PsGsUfl3tW2i0arHpzn5CyFa_nXwE-b5ibP3T7oeNqOsqEJkkl00kXMIKU0Dc5I1hmmXaeJFLnQkrufMsL2LuhLZcSHBHHLdZnmtXgGOQj60uPIfnXiFXBQdLjpXp65975Of4ia0vzJHpah2zkJDERIQ1n1mUDYxf6BHwvyU4ZwqHaZrn7N76LXKzc1jpWqtht8mSK--QG-1pH22LmO6S35OS_pg2pxUFhQUda-shqS4tbapfUwOuPtULDlBaeYrZJ2F8VtVNhAf-SH8N7i8Nfaaqk8pOPbjHtIQf5lif1fAkeqKx49gRYGBNMWP_kCLdctQ1G5rNGwooCJE5jvRs6a6-R_YuRUT3yXJZle4hocbHY-ul4Fo6kdmkgJBLFsU4tcwWksUjEvcSUaZjRcfmHMcqREcyVa0UFUhRBSmqbETeLO6ZtZwgF85-j4JezEQ-73ABllN18KAAN_PEj2NjEivAKczH3Cdc6IJbl9uYjcgLVBOFjB0lpgQd6nldq8m3r2otk2mg3ElH5HU3yVfwDkZ3FRawEkjyNZi5MpgJkGKGw702qg7SavVvA47I88Uw3olpeqWr5rUKjdCQEk6MyINWeRfvzSUyDcWwHnKg1oOFGY6U06NAeB4jWyYTyaOL_9czcm1jd3tLbU12Nh-T6yxsPB6xeIUsN6dz9wTcx6Z4GvYsJQeXDRJ_ARzvhpQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=In+vitro+inflammation+and+toxicity+assessment+of+pre-+and+post-incinerated+organomodified+nanoclays+to+macrophages+using+high-throughput+screening+approaches&rft.jtitle=Particle+and+fibre+toxicology&rft.au=Todd+A.+Stueckle&rft.au=Jake+Jensen&rft.au=Jayme+P.+Coyle&rft.au=Raymond+Derk&rft.date=2024-03-21&rft.pub=BMC&rft.eissn=1743-8977&rft.volume=21&rft.issue=1&rft.spage=1&rft.epage=28&rft_id=info:doi/10.1186%2Fs12989-024-00577-7&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_57895f01cc5d4658903f534ab3de9d12 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1743-8977&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1743-8977&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1743-8977&client=summon |